$0.53
arrow_drop_up9.26%Key Stats | |
---|---|
Open | $0.50 |
Prev. Close | $0.49 |
EPS | -1.18 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
Market Cap | $12.78M |
PE Ratio | - |
LOW | HIGH | |
---|---|---|
Day Range | 0.49 | 0.54 |
52 Week Range | 0.38 | 1.94 |
Ratios | |
---|---|
Revenue | - |
EBITDA Margin % | - |
EPS | -1.18 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
VISTA Inhibitor Clinical Trials Drug Approval Insight - GlobeNewswire
Sensei Biotherapeutics to Participate in Jefferies Global Healthcare Conference
Sensei Biotherapeutics Presents Promising Clinical Data from Phase 1 Dose Escalation Study of SNS-101
Sensei Biotherapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
Sensei Biotherapeutics to Present Topline Clinical Data from the SNS-101 Phase I Dose Escalation Study at the 2024 ASCO Annual Meeting
Sensei Biotherapeutics to Participate in Canaccord Genuity’s Horizons in Oncology Virtual Conference